DH
Daniel Hsu
Director Of Qa/Qc/Ra at Advin Biotech,
View Daniel's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Director Of Qa/Qc/Ra
Nov 2018 - Present · 6 years and 2 months
Senior Manger
Jan 2006 - Mar 2018 · 12 years and 2 months
Kiotek Corporation
Manager
Oct 2003 - Jan 2006 · 2 years and 3 months
Company Details
11-50 Employees
Advin Biotech is a FDA Registered growing corporation and manufacturer specializing in rapid diagnostics products for drugs of abuse testing with China and US based manufacturing facilities. Offering a complete line of one step drug tests for medical workplace and criminal justice professionals. Advin’s 501k cleared products are intended for OTC, CLIA and professional use in cup, dip-card and cassette test formats. With full R&D and manufacturing capabilities located in our San Diego, California plant we are positioned to respond to the needs of partners and customers worldwide. We have the intra-company organic chemistry expertise to facilitate the design and synthesis of immunogens and the complementing ability to use the resulting immunogens to generate antibodies for the sensitive and specific detection of antigens and biomarkers. We encourage partnerships and co-development opportunities accordingly. Our short-term strategic goal is to augment our existing FDA cleared test menu with first-to-market, “organically-grown” assays targeted to fill the many gaps in the diverse toxicology market. Our long-term goal is to foster partnerships in the worldwide medical and forensic communities with a shared goal of providing affordable, accurate and actionable tests that fill unmet needs.
Year Founded
2009
Social Media
LinkedinTwitter
Industry
Medical Device
HQ Location
10320 Camino Santa Fe San Diego, California, US
Keywords
--
Discover More About Cleveland Clinic

Find verified contacts of Daniel Hsu in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.